Search research articles
Contact Us
Filters
Showing results (151-160 of 230) with videos related to
Page
of 23
Sort By:
Chinese Medicine
|
May 21, 2026
Targeted degradation of aberrant Tau for the discovery of Pulsatilla chinensis in Alzheimer's disease
Lan Deng, Can Yin, Xiaogang Zhou, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
August 31, 2021
Vectorial Compound Metapixels for Arbitrary Nonorthogonal Polarization Steganography
Zi-Lan Deng, Qing-An Tu, Yujie Wang, et al.
BMJ Open
|
September 14, 2023
Incidence, characteristics and outcome of post-stroke recrudescence in the Chinese population: a single-centre observational study
Ming-Jun Pu, Jia-Lun Yu, Xiao Hu, et al.
Nano Letters
|
March 3, 2025
Achieving Higher-Order Exceptional Points in a Terahertz Metasurface
Peng Fu, Peng Pai, Wenze Lan, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
August 17, 2018
[Etiological Study of Late Onset Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation in Children]
Lan-Lan Deng, Kun-Yin Qiu, Xiong-Yu Liao, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
March 21, 2024
Optimal intraventricular hemorrhage volume cutoff for predicting poor outcome in patients with intracerebral hemorrhage
Lan Deng, Jiang-Tao Zhang, Xin-Ni Lv, et al.
Frontiers in Endocrinology
|
December 6, 2024
Study on the characteristics of carotid wall shear stress in type 2 diabetes patients based on ultrasound vector flow imaging
Zhaohuan Li, Anguo Luo, Xuebing Liu, et al.
Acta Pharmacologica Sinica
|
May 15, 2021
Bispecific antibody simultaneously targeting PD1 and HER2 inhibits tumor growth via direct tumor cell killing in combination with PD1/PDL1 blockade and HER2 inhibition
Chang-Ling Gu, Hai-Xia Zhu, Lan Deng, et al.
Translational Oncology
|
October 31, 2020
Tumor-targeting anti-EGFR x anti-PD1 bispecific antibody inhibits EGFR-overexpressing tumor growth by combining EGFR blockade and immune activation with direct tumor cell killing
Li Li, Lan Deng, Xiaoqing Meng, et al.
Microsystems & Nanoengineering
|
April 13, 2026
Open micro-valley chip reveals long-term viscosity-induced glioblastoma cellular invasion states
Haotian Jiang, Chao Xu, Cheng Zeng, et al.
Page
of 23
Search research articles
Search
Showing results (151-160 of 230) with videos related to
Sort By:
Page
of 23
Chinese Medicine
|
May 21, 2026
Targeted degradation of aberrant Tau for the discovery of Pulsatilla chinensis in Alzheimer's disease
Lan Deng, Can Yin, Xiaogang Zhou, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
August 31, 2021
Vectorial Compound Metapixels for Arbitrary Nonorthogonal Polarization Steganography
Zi-Lan Deng, Qing-An Tu, Yujie Wang, et al.
BMJ Open
|
September 14, 2023
Incidence, characteristics and outcome of post-stroke recrudescence in the Chinese population: a single-centre observational study
Ming-Jun Pu, Jia-Lun Yu, Xiao Hu, et al.
Nano Letters
|
March 3, 2025
Achieving Higher-Order Exceptional Points in a Terahertz Metasurface
Peng Fu, Peng Pai, Wenze Lan, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
August 17, 2018
[Etiological Study of Late Onset Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation in Children]
Lan-Lan Deng, Kun-Yin Qiu, Xiong-Yu Liao, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
March 21, 2024
Optimal intraventricular hemorrhage volume cutoff for predicting poor outcome in patients with intracerebral hemorrhage
Lan Deng, Jiang-Tao Zhang, Xin-Ni Lv, et al.
Frontiers in Endocrinology
|
December 6, 2024
Study on the characteristics of carotid wall shear stress in type 2 diabetes patients based on ultrasound vector flow imaging
Zhaohuan Li, Anguo Luo, Xuebing Liu, et al.
Acta Pharmacologica Sinica
|
May 15, 2021
Bispecific antibody simultaneously targeting PD1 and HER2 inhibits tumor growth via direct tumor cell killing in combination with PD1/PDL1 blockade and HER2 inhibition
Chang-Ling Gu, Hai-Xia Zhu, Lan Deng, et al.
Translational Oncology
|
October 31, 2020
Tumor-targeting anti-EGFR x anti-PD1 bispecific antibody inhibits EGFR-overexpressing tumor growth by combining EGFR blockade and immune activation with direct tumor cell killing
Li Li, Lan Deng, Xiaoqing Meng, et al.
Microsystems & Nanoengineering
|
April 13, 2026
Open micro-valley chip reveals long-term viscosity-induced glioblastoma cellular invasion states
Haotian Jiang, Chao Xu, Cheng Zeng, et al.
Page
of 23